Full-Time

Staff Product Development Engineer

Jupiter Endovascular

Jupiter Endovascular

11-50 employees

Develops and sells endovascular cardiovascular devices

Compensation Overview

$160k - $180k/yr

+ Equity + 401(k) Match

Menlo Park, CA, USA

In Person

Category
Biology & Biotech (1)
Required Skills
CAD
Word/Pages/Docs
Risk Management
SolidWorks
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • B.S. or M.S. in Mechanical Engineering, Biomedical Engineering, or a related discipline required
  • 8+ years of work experience as a hands-on engineer required
  • Strong understanding of all elements (design and design controls) required to take a product from feasibility to launch
  • Draw conclusions and make recommendations based on technical inputs from multiple and varied sources, combined with a good understanding of the relevant technologies
  • A willingness to work hard with a driven outlook and with a strong desire to succeed as an engineer, as a team player, and as a company
  • Technical writing skills, documentation, and proficient in general computer skills including Word, Excel, PowerPoint, and email communication
  • Proficient in CAD (SolidWorks or OnShape)
  • Strong verbal and written communication skills and the ability to communicate effectively across all levels of the organization
Responsibilities
  • Bring an experimental and analytical approach while creating specific designs for endovascular applications
  • Work with typical and novel catheter technologies
  • Participate in the development of specifications, test methods, and protocols to ensure the functionality, safety, and efficacy of medical devices in accordance with medical device regulations and design controls
  • Lead assessments and make recommendations for solving challenging design problems at both component and system levels via inspection, testing, analysis, and experimentation
  • Be a mentor and provide guidance to junior engineers, technicians, and interns
  • Be a technical leader on key projects
  • Significant hands-on building and testing of multiple generations of prototypes
  • Apply Design for Manufacturability principles
  • Manage third party vendors to ensure deliverables meet product and timeline requirements
  • Interact with physicians to inform design decisions
  • Lead continuous improvement projects such as design changes for materials, components, finished products, processes, and related procedures
  • Manage and participate in design verification and validation to confirm outputs meet design requirement parameters
  • Collaborate with Quality Assurance on risk management activities per ISO 14971
  • Create and maintain CAD models and drawings
  • Generate novel ideas that strengthen the company’s intellectual property position
  • Collaborate closely and show a high degree of self-direction

Jupiter Endovascular develops and sells advanced endovascular devices to improve cardiovascular health, serving hospitals and cardiovascular clinics worldwide. Its products are catheter-based tools used in endovascular procedures, developed, cleared by regulators, and clinically validated before being sold to healthcare providers. The company differentiates itself through a strong focus on clinical affairs and product management, plus a global market presence and strategic partnerships to broaden reach while prioritizing safety and proven efficacy. Its goal is to improve patient cardiovascular outcomes by delivering reliable, clinically validated endovascular solutions to healthcare providers around the world.

Company Size

11-50

Company Stage

Series B

Total Funding

$40M

Headquarters

Menlo Park, California

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Vertex Catheter received FDA 510(k) clearance on September 24, 2025, enabling commercialization.
  • Oversubscribed $40M Series B led by Sonder Capital funds SPIRARE II and TFX expansion.
  • Fred Ong joined as CFO to bolster finance during 2026 growth phase.

What critics are saying

  • Inari Medical's FlowTriever captures 70% pulmonary embolism market share in 2024.
  • SPIRARE I results at TCT 2025 show mediocre efficacy, halting SPIRARE II.
  • FDA warning letter delays TFX commercialization, exhausting $40M runway in 2026.

What makes Jupiter Endovascular unique

  • TFX technology shifts catheters from flexible to firm for precise pulmonary embolectomy.
  • Vertex Catheter with Endoportal Control enables stable positioning in pulmonary vasculature.
  • SPIRARE II trial completed enrollment for acute pulmonary embolism treatment.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Jupiter Endovascular who can refer or advise you

Benefits

401(k) Retirement Plan

Remote Work Options

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Hybrid Work Options

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Conference Attendance Budget

Professional Development Budget

Stock Options

Company Equity

Company News

FinSMEs
Oct 7th, 2025
Jupiter Endovascular Closes Series B Funding

Jupiter Endovascular, a Menlo Park, CA-based medical technology startup, closed its Series B funding at over $40M

Stock Titan
Oct 7th, 2025
Jupiter Endovascular Raises Over $40M Series B

Jupiter Endovascular closed an oversubscribed Series B financing round, surpassing its $40 million target. Led by Sonder Capital, with participation from Senvest Management, LB Investment, and a new strategic corporate investor, the funds will support the SPIRARE II clinical trial, commercialization, and new applications for its TFX technology. The Vertex Catheter with TFX recently received FDA 510(k) clearance, and SPIRARE I trial results will be presented at TCT 2025.

Informa Markets Engineering
Oct 7th, 2025
Jupiter Endovascular Surpasses Funding Goal, Hits FDA Milestone

Jupiter Endovascular has raised over $40M in Series B funding led by Sonder Capital to advance its TFX platform and SPIRARE II trial.

Medical Product Outsourcing
Feb 26th, 2025
Jupiter Endovascular Hires Fred Ong as Finance Chief

Jupiter Endovascular revealed that experienced medtech finance and operations exec Fred Ong has joined the company as chief financial officer (CFO).

FinSMEs
Aug 15th, 2024
Jupiter Endovascular Raises $21M in Funding

Jupiter Endovascular, Inc., a Menlo Park, CA-based medical technology startup, exited stealth mode with a $21M new round of financing